With the approval, the appliances represent an alternative treatment to CPAP or surgical neurostimulation implants for patients with severe OSA. "This achievement is a pivotal milestone for Vivos, and elevates our proven treatment options right into the mainstream of sleep medicine," Kirk Huntsman, chairman and chief executive officer at Vivos, https://shermanf322ukb0.vidublog.com/profile